Medical Physics

Medical Physics

The areas of interest concern, on the one hand, the use of charged particles of hadronic type for the treatment of tumors (so-called hadrotherapy) and the development of detectors for the evaluation of the biological effects they induce; on the other hand, the activity related to medical diagnostics and the development of imaging detectors and techniques for capturing and processing biomedical images.
Recently, the installation of a high-intensity Cyclotron at the Legnaro INFN Laboratories that can accelerate protons up to 70 MeV, the central element of the SPES (Selective Production of Exotic Species) program, and the construction of an infrastructure for research and production of innovative radionuclides of medical interest (LARAMED = LAboratory RAdioisotopes for MEDicine), launched research projects devoted both to the production with unconventional techniques of radioisotopes already widely used in nuclear medicine (such as 99mTc) and that of radioisotopes potentially useful but difficult to produce and therefore currently not available in adequate quantities for medical applications.
Radiopharmaceuticals, chemical compounds containing one or more radioactive nuclides, are the basic tools used by nuclear medicine to obtain non-invasive diagnostic information about the body's internal tissues or to induce a therapeutic effect on diseased tissues.
The development of new radiopharmaceuticals is linked to the combination of nuclear, chemical and biological properties of the compound and therefore requires the interaction of physicists, engineers, chemists, biologists and medical doctors in a highly interdisciplinary activity.